1. Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review

   • L. Ung
   • A. K.-Y. Lam
   • T. C. Chua

   Educational Series - Blue Series 24 January 2014 Pages: 425 - 435

2. Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline

   • M. J. Gil-Gil
   • M. Martinez-Garcia
   • S. Villà

   Educational Series - Red Series Open access 26 November 2013 Pages: 436 - 446

   

3. Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer

   • J. López Torrecilla
   • A. Zapatero
   • On behalf of the Grupo de Investigación GICOR-URONCOR-SEOR

   Special Article 25 October 2013 Pages: 447 - 454

   

4. Serum integrin-linked kinase (sILK) concentration and survival in non-small cell lung cancer: a pilot study

   • F. Posch
   • U. Setinek
   • S. B. Watzka

   Research Article 27 August 2013 Pages: 455 - 462

   

5. Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) study

   • C. C. Zhou
   • C. X. Bai
   • Y. Z. Zhu

   Research Article 04 September 2013 Pages: 463 - 468

6. Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer

   • T. Xu
   • X. Liu
   • Y. Shu

   Research Article 10 September 2013 Pages: 469 - 475

   

7. Observations on the effects of Suppressor of Cytokine Signaling 7 (SOCS7) knockdown in breast cancer cells: their in vitro response to Insulin Like Growth Factor I (IGF-I)

   • W. Sasi
   • L. Ye
   • A. Sharma

   Research Article 18 September 2013 Pages: 476 - 487

   

8. Overexpression of nuclear β-catenin at invasive front in rectal carcinoma is associated with lymph node metastasis and poor prognosis

   • L. Wang
   • X. Zhang
   • S. Hu

   Research Article 17 September 2013 Pages: 488 - 494

   

9. Efficacy of rapamycin against glioblastoma cancer stem cells

   • M. Mendiburu-Eliçabe
   • J. Gil-Ranedo
   • M. Izquierdo

   Research Article 17 September 2013 Pages: 495 - 502

   

10. The impact of computed tomography slice thickness on the assessment of stereotactic, 3D conformal and intensity-modulated radiotherapy of brain tumors

    • R. Caivano
    • A. Fiorentino
    • V. Fusco

    Research Article 20 September 2013 Pages: 503 - 508

    

11. Positron emission tomography (PET) is not indicated in the postchemotherapy evaluation of advanced non-seminomatous testicular germ cell tumors

    • J. Aparicio
    • On behalf of the Spanish Germ Cell Cancer Group

    Correspondence 15 February 2014 Pages: 509 - 510